Private Prescription Route: Compare Wegovy vs Mounjaro Today
What's The Difference Between Wegovy And Mounjaro Through Private Prescription?
The fundamental difference between Wegovy and Mounjaro lies in their receptor targeting mechanisms, which becomes particularly relevant when accessing these treatments privately in the UK. Wegovy (semaglutide) works as a single GLP-1 receptor agonist, mimicking the natural incretin hormone that regulates appetite and blood sugar. Mounjaro (tirzepatide) functions as a dual agonist, targeting both GIP and GLP-1 receptors simultaneously. This dual mechanism may offer different metabolic effects, though both medications require the same private prescription process through qualified healthcare providers.
Private prescription access eliminates the lengthy NHS specialist referral pathway, where patients typically wait 6+ months for weight management clinic appointments. Through EverydayMeds' streamlined service, both Wegovy and Mounjaro are available following a comprehensive clinical assessment and prescriber review. Our GPhC-registered pharmacy (#9012878) ensures the same pharmaceutical-grade medications dispensed through NHS channels, but with the convenience of direct access and next-day delivery to your door.
Wegovy vs Mounjaro Pricing: What's The Difference Between Costs?
Understanding what's the difference between Wegovy and Mounjaro pricing helps inform your treatment decision, particularly for ongoing maintenance therapy. Wegovy pricing starts at £79.99 for the 0.25mg starter dose (with FIRST40 discount code for new customers), progressing through dose escalation to £209.99 for the 2.4mg maintenance dose. Our bundle options provide convenient multi-month supplies, such as the Intro Trio (0.25mg, 0.5mg, and 1mg) for £299.99, covering your first 12 weeks of treatment.
Mounjaro follows a similar private prescription pricing structure, though specific costs vary by dose strength and treatment phase. Both medications offer returning customer discounts through code DOSE25, making long-term weight management more accessible. The Ultimate Stability Trio provides three months of 2.4mg Wegovy maintenance supply for £649.99, ensuring treatment continuity without frequent reordering. Remember, these are prescription-only medicines requiring ongoing clinical supervision regardless of the supply route chosen.
Clinical Evidence: What's The Difference Between Wegovy And Mounjaro Studies?
The clinical evidence base highlights what's the difference between Wegovy and Mounjaro in terms of study design and participant populations. Wegovy's efficacy was demonstrated in the STEP trial programme, where participants taking semaglutide alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP trials enrolled adults with BMI ≥30 or ≥27 with weight-related comorbidities, matching current UK licensing criteria.
Mounjaro's clinical programme involved different trial designs and endpoints, making direct percentage comparisons inappropriate. Both medications demonstrated cardiovascular benefits in their respective studies, with Wegovy's SELECT trial showing a 20% reduction in major cardiovascular events. These findings support both treatments as evidence-based options for weight management, though individual responses may vary based on personal health factors and adherence to lifestyle modifications.
How Wegovy Works: Understanding The Difference From Mounjaro's Mechanism
Wegovy functions as a GLP-1 receptor agonist, working on specific brain centres that control appetite and satiety signals. When administered weekly via the FlexTouch pen, semaglutide may help reduce food cravings and promote feelings of fullness after smaller meals. The medication slows gastric emptying, potentially extending the time you feel satisfied after eating. This mechanism mimics natural incretin hormones your body produces in response to food intake. Unlike Mounjaro's dual-receptor approach, Wegovy's single-pathway targeting offers a well-established mechanism backed by extensive clinical experience in both diabetes and weight management applications.
Private Prescription Ordering: What's The Difference Between Wegovy And Mounjaro Access?
The ordering process remains identical whether you're prescribed Wegovy or Mounjaro through our private service, though the specific clinical assessment questions may vary based on your chosen treatment. Our 3-minute online assessment captures your medical history, current medications, and weight management goals. Qualified prescribers review your application within 3 working days (or 24 hours with express service), determining suitability for your preferred medication. Once approved, your prescription-only medicine is dispatched via next-day cold-chain delivery, maintaining the 2-8°C storage requirements throughout transit. This streamlined approach bypasses traditional GP referral bottlenecks while ensuring appropriate medical oversight.
Storage And Practical Considerations: Key Differences Between Wegovy And Mounjaro
A practical difference between Wegovy and Mounjaro lies in their room temperature storage capabilities, particularly relevant for frequent travellers or those with limited refrigerator space. Wegovy pens can withstand up to 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day limit. Both medications require initial storage at 2-8°C and use similar injection pen technology for weekly administration. The FlexTouch pen system delivers pre-measured doses subcutaneously, typically in the thigh, upper arm, or abdomen. Dose escalation follows mandatory schedules for both treatments, starting with lower doses to minimise potential gastrointestinal side effects before reaching therapeutic maintenance levels.
What's The Difference Between Wegovy And Mounjaro For Private UK Patients?
For UK patients seeking private prescription access, the choice between Wegovy and Mounjaro often depends on individual clinical factors rather than availability or convenience differences. Both treatments require identical regulatory compliance, including MHRA licensing and prescription-only medicine classification. Your prescriber will consider your medical history, concurrent medications, and previous weight management attempts when recommending either option.
The private route offers consistent access to both medications, avoiding NHS supply chain disruptions that have historically affected specialist weight management services. EverydayMeds maintains robust stock levels of both treatments, ensuring treatment continuity for established patients. This reliability factor often influences patient choice, particularly for those who have experienced NHS prescription delays or clinic appointment cancellations.
Making Your Decision: Wegovy vs Mounjaro Through EverydayMeds
Both Wegovy and Mounjaro represent evidence-based approaches to weight management, available through our comprehensive private prescription service alongside a reduced-calorie diet and increased physical activity. New customers can begin their assessment today using discount code FIRST40, while returning patients benefit from ongoing support through code DOSE25. Our clinical team provides personalised guidance throughout your treatment journey, from initial prescription through dose escalation and maintenance phases. The choice between these medications should be made in consultation with qualified healthcare providers who can assess your individual circumstances. Start your confidential assessment at https://everydaymeds.co.uk/collections/wegovy to explore which option may be most suitable for your weight management goals.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
